France Interventional Cardiology Market Outlook to 2033 - Coronary Stents, PTCA Balloon Catheters, Transcatheter Accessories and Others
Summary
GlobalData’s “France Interventional Cardiology Market Outlook to 2033” is a comprehensive databook report, covering key market data on the France Interventional Cardiology market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloon Catheters, Structural Heart Occlusion Devices, Transcatheter Accessories
The France Interventional Cardiology Market report provides key information and data on -
Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
2023 company share and distribution share data for Interventional Cardiology Market.
Global corporate-level profiles of key companies operating within the France Interventional Cardiology Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
Scope
France Interventional Cardiology is segmented as follows -
Coronary Stents
Intravascular Ultrasound Systems (IVUS)
PTCA Balloon Catheters
Structural Heart Occlusion Devices
Transcatheter Accessories
Reasons to Buy
France Interventional Cardiology Market report helps you to develop -
Business strategies by identifying the key market segments poised for strong growth in the future.
Market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Interventional Cardiology Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Interventional Cardiology Market, France
3.1 Interventional Cardiology Market, France, Revenue ($m), 2018-2033
3.1.1 Coronary Stents Market, France, Revenue ($m), by Segment, 2018-2033
3.1.2 Intravascular Ultrasound Systems (IVUS) Market, France, Revenue ($m), by Segment, 2018-2033
3.1.3 PTCA Balloon Catheters Market, France, Revenue ($m), by Segment, 2018-2033
3.1.4 Structural Heart Occlusion Devices Market, France, Revenue ($m), by Segment, 2018-2033
3.1.5 Transcatheter Accessories Market, France, Revenue ($m), by Segment, 2018-2033
3.2 Interventional Cardiology Market, France, Volume (Units), 2018-2033
3.2.1 Coronary Stents Market, France, Volume (Units), by Segment, 2018-2033
3.2.2 Intravascular Ultrasound Systems (IVUS) Market, France, Volume (Units), by Segment, 2018-2033
3.2.3 PTCA Balloon Catheters Market, France, Volume (Units), by Segment, 2018-2033
3.2.4 Structural Heart Occlusion Devices Market, France, Volume (Units), by Segment, 2018-2033
3.2.5 Transcatheter Accessories Market, France, Volume (Units), by Segment, 2018-2033
3.3 Interventional Cardiology Market, France, Average Price ($) , 2018-2033
3.4 Interventional Cardiology Market, France, Distribution Share by Revenue ($m), 2023
3.5 Interventional Cardiology Market, France, Company Share by Revenue ($m), 2023
4 Overview of Key Companies in France, Interventional Cardiology Market
6.1.1 Inari Medical Acquires LimFlow for Upto USD415 Million
6.2 Partnerships
6.2.1 Sartorius Enters into Co-Development Agreement with Sanofi
6.3 Private Equity
6.3.1 Consortium of Investors May Acquire Sanofi for USD20 Billion
7 Recent Developments
7.1 Corporate Communications
7.1.1 Feb 22, 2024: Sanofi’s Board of Directors Proposes the Appointment of Clotilde Delbos, Anne-Francoise Nesmes and John Sundy as Independent Directors
7.1.2 Feb 01, 2024: Francois-Xavier Roger Appointed Chief Financial Officer, Member of Sanofi Executive Committee
7.1.3 Jan 09, 2024: Brian Foard Appointed Head of Specialty Care Global Business Unit, Member of Sanofi Executive Committee